Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
Clinical trial NCT00169104 · TERMINATED
Trial details
- NCT number
- NCT00169104
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2009-03-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.